RIDE-001

N/A

Report date: 2026/01/30 17:28:05

Base Information

Drug NameRIDE-001
Drug Alias NameRIDE-001RIDE001
ClassificationBiologicsSmall molecules > LipidBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNucleotide-binding oligomerization domain-containing protein 2 stimulants
TargetsNucleotide-binding oligomerization domain-containing protein 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrained Therapeutix Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrained Therapeutix Discovery Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A